Skip to content
KFF Health News KFF Health News KFF Health News KFF Health News
Donate
  • Donate
  • Connect With Us:
  • Contact
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS
  • Trump 2.0
    • Agency Watch
    • Medicaid Watch
    • State Watch
    • Rural Health Payout
  • Public Health
  • Race & Health
  • Audio
    • KFF Health News Minute
    • What the Health?
    • Health Care Helpline
    • An Arm and a Leg
    • Silence in Sikeston
    • Epidemic
  • Investigations
    • Bill Of The Month
    • Deadly Denials
    • The Body Shops
    • Broken Rehab
    • Guns, Race, and Profit
    • Dead Zone
    • Payback: Tracking Opioid Cash
    • Overpayment Outrage
    • Diagnosis: Debt
    • ALL INVESTIGATIONS
  • More Topics
    • Abortion
    • Aging
    • Climate
    • COVID-19
    • Health Care Costs
    • Insurance
    • Medicaid
    • Medicare
    • Mental Health
    • Pharma
    • Rural Health
    • Uninsured
Wednesday, Aug 7 2024

Pharma and Tech: Aug. 8, 2024

Since Fall of ‘Roe,’ Self-Managed Abortions Have Increased
By Sarah Varney The percentage of people who say they’ve tried to end a pregnancy without medical assistance increased after "Roe v. Wade" was overturned. One of the most common reasons for seeking a self-managed abortion was privacy concerns.

What the Health? From KFF Health News: Harris in the Spotlight
For the 2024 campaign, Joe Biden is out, and Kamala Harris is in. As the vice president makes moves toward the top of the Democratic presidential ticket, health policy is resurging as a campaign issue. Meanwhile, Congress tries — and again fails — to make timely progress on the annual government spending bills as abortion issues cause delays. Alice Miranda Ollstein of Politico, Stephanie Armour of KFF Health News, and Rachel Cohrs Zhang of Stat join KFF Health News’ Julie Rovner to discuss these issues and more. Also this week, Rovner interviews Anthony Wright, the new executive director of Families USA, about his plans for the organization and his history working with Harris on health topics. 

Louisiana Reclassifies Drugs Used in Abortions as Controlled Dangerous Substances
By Rosemary Westwood, WWNO Louisiana lawmakers have added two drugs commonly used in pregnancy and reproductive health care to the state’s list of controlled dangerous substances, a move that has alarmed doctors in the state.

World-Famous Wall Drug Isn’t Immune From Challenges Facing Rural Pharmacies
By Arielle Zionts Even as part of a popular South Dakota tourist attraction, an independent pharmacy serving locals, remote ranchers, and sightseers struggles with staffing and insurer payments.

Why Millions Are Trying FDA-Authorized Alternatives to Big Pharma’s Weight Loss Drugs
By Arthur Allen Illustration by Oona Zenda Although Novo Nordisk and Lilly lump together the pharmacies that compound semaglutide and tirzepatide with internet cowboys selling fake drugs, there is a distinction. The FDA has offered Americans little clarity about the vast gray and black markets for the drugs.

Harris, Once Biden’s Voice on Abortion, Would Take an Outspoken Approach to Health
By Stephanie Armour and Julie Appleby and Julie Rovner If she grabs the baton from President Joe Biden to become the new presumptive Democratic presidential nominee, Kamala Harris would widely be expected to take an aggressive stance in support of abortion access — hitting former President Donald Trump on an issue that could undermine his chances of victory.

The Supreme Court Just Limited Federal Power. Health Care Is Feeling the Shockwaves.
By Stephanie Armour A Supreme Court ruling restricting federal power will likely have seismic ramifications for health policy. A flood of litigation — with plaintiffs like small businesses, drugmakers, and hospitals challenging regulations they say are too expensive or burdensome and not authorized by law — could leave the country with a patchwork of disparate health regulations.

What the Health? From KFF Health News: SCOTUS Rejects Abortion Pill Challenge — For Now 
The Supreme Court has dismissed a challenge to the FDA’s approval of the abortion pill mifepristone, ruling unanimously that the anti-abortion doctor group that filed the suit lacked standing. But abortion opponents are expected to pursue other strategies to ban or restrict the medication. Meanwhile, the Biden administration moves to stop the inclusion of medical debt on individual credit reports, and former President Donald Trump tries to claim credit for $35 insulin. Anna Edney of Bloomberg News, Rachana Pradhan of KFF Health News, and Emmarie Huetteman of KFF Health News join KFF Health News chief Washington correspondent Julie Rovner to discuss these stories and more. Also this week, Rovner interviews KFF president and CEO Drew Altman about KFF’s new “Health Policy 101” primer.

Biden Plan To Save Medicare Patients Money on Drugs Risks Empty Shelves, Pharmacists Say
By Susan Jaffe President Joe Biden is campaigning for reelection on his efforts to cut costs for Medicare patients at the pharmacy counter. But independent pharmacists say one strategy makes it unaffordable for them to keep some brand-name medicines in stock.

Shingles Vaccine May Stall Dementia, and Vaccine Mandates Save Lives, Studies Suggest
KFF Health News senior fellow and editor-at-large for public health Céline Gounder discussed vaccines in a couple of recent media appearances.

Rescue From Above: How Drones May Narrow Emergency Response Times
By Michelle Andrews Public safety and health care organizations are using drones to speed up lifesaving treatment during medical emergencies in which every second counts.

Social Media Bans Could Deny Teenagers Mental Health Help
By Daniel Chang Illustration by Oona Zenda Congress and state legislatures are considering age bans and other limits for Instagram and TikTok out of concern that they harm kids’ mental health. But some researchers and pediatricians question whether there’s enough data to support that conclusion.

Montana’s Plan To Curb Opioid Overdoses Includes Vending Machines
By Mara Silvers, Montana Free Press Details about where the machines would go — and how they would help those most at risk — are sparse. The state has proposed using them to distribute naloxone and fentanyl testing strips.

Biden Administration Tightens Broker Access to Healthcare.gov To Thwart Rogue Sign-Ups
By Julie Appleby The Centers for Medicare & Medicaid Services said it has received more than 200,000 complaints in the first six months of the year about people being signed up for Obamacare plans or switched to new plans without their consent.

Qué son los medicamentos compuestos que millones de personas usan para bajar de peso
By Arthur Allen La FDA permite e incluso fomenta que las farmacias de compuestos produzcan y vendan copias cuando un medicamento está en escasez, como es el caso de las drogas para combatir el sobrepeso y la obesidad.

Harris, alguna vez la voz de Biden sobre el aborto, tendría un enfoque abierto en temas de salud
By Stephanie Armour and Julie Appleby and Julie Rovner Mientras los demócratas reconstruyen su candidatura presidencial a pocos meses de las elecciones, se esperaría que, de ser la nueva nominada, Harris adoptase una postura agresiva en apoyo al acceso al aborto y en otros temas controversiales de salud.

We want to hear from you: Contact Us

Previous
KFF Health News’ Weekly Edition: Aug. 2, 2024
Next
KFF Health News Weekly Edition: Aug. 9, 2024

More From KFF Health News

A photo of Robert F. Kennedy Jr. at his confirmation hearing in a Senate hearing room.

RFK Jr. Made Promises in Order To Become Health Secretary. He’s Broken Many of Them.

Journalists Unpack Impact of ICE Arrests on Families and Caffeine’s Effect on Dementia Risk

A physician stands in an examination room at a clinic. She has a stethoscope draped over her neck.

Clinics Sour on CMS After Agency Scraps 10-Year Primary Care Program Only Months In

A photo of a White House event: President Trump sits at a table. To the right of him is Robert F. Kennedy Jr. Mehmet Oz sits to Kennedy's right. All three men have microphones across from them.

Trump Team’s Planned ACA Rule Offers Its Answer to Rising Premium Costs: Catastrophic Coverage

KFF

© 2026 KFF. All rights reserved.

  • About Us
  • Donate
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Staff
  • Republish Our Content
  • Email Sign-Up
  • X
  • Facebook
  • LinkedIn
  • Instagram
  • RSS

Powered by WordPress VIP

Thank you for your interest in supporting KFF Health News, the nation’s leading nonprofit newsroom focused on health and health policy. We distribute our journalism for free and without advertising through media partners of all sizes and in communities large and small. We appreciate all forms of engagement from our readers and listeners, and welcome your support.

KHN is an editorially independent program of KFF (Kaiser Family Foundation). You can support KHN by making a contribution to KFF, a non-profit charitable organization that is not associated with Kaiser Permanente.

Click the button below to go to KFF’s donation page which will provide more information and FAQs. Thank you!

Continue